Josephia R. Muindi

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Josephia R. Muindi, SR Frankel, WH Jr Miller et al. · Blood · 1992 · 411 citations · Full text

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Josephia R. Muindi, SR Frankel, WH Jr Miller et al. · Blood · 1992 · 318 citations · Full text

Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.

Josephia R. Muindi, Stanley R. Frankel, Christine Huselton et al. · PubMed · 1992 · 292 citations

Hematological Malignancy, All-trans Ra, Oncology +15

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.

David C. Smith, C S Johnson, C C Freeman et al. · PubMed · 1999 · 173 citations

Urology, Oncology, Medicine +13

Feasibility of Retinoids for the Treatment of Emphysema Study

Michael D. Roth, John E. Connett, Jeanine D’Armiento et al. · CHEST Journal · 2006 · 159 citations

Emphysema Study, Ocular Disease, Ophthalmology